Generic drug of the therapeutic class: Dermatology
active ingredients: Betamethasone
laboratory: Msd France
15 g tube
- Corticosensitive lesions, limited in surface, having resisted a corticoid of the lower category.
- Limited and resistant plaques of psoriasis especially in their palmoplantar locations, lichenifications (neurodermatitis), discoid lupus erythematosus, lichens,
- Hypertrophic scars.
Note : After a generally brief attack treatment, the relay is possibly provided by a corticosteroid of a lower class.
Dosage DIPROLENE 0.05% Ointment 15 g tube
Applications are limited to 2 per day. An increase in the number of daily applications could aggravate the adverse effects without improving the therapeutic effects.
The treatment of large areas requires monitoring of the number of tubes used.
Spread the product on the lesions and penetrate by a light massage.
Stopping treatment will be gradual by reducing the frequency of applications and / or by the use of a corticosteroid less strong or less dosed.
- Hyper-sensitivity to one of the compounds.
- Bacterial, viral, primitive and parasitic fungal infections even if they have an inflammatory component.
- Ulcerated lesions.
- Acne and rosacea.
- Infant (see warnings).
NOT RECOMMENDED :
Pregnancy: The safety of this drug during pregnancy has not been established, so use is not recommended during the first three months of pregnancy.
Diprolene side effects
- Are feared in case of prolonged use: cutaneous atrophy, telangiectasia (to be feared especially on the face), stretch marks (at the root of the limbs in particular and occurring more readily in adolescents); ecchymotic purpura secondary to atrophy, skin fragility.
- In the face, corticosteroids can create peri-oral dermatosis or create or aggravate rosacea (see warnings and contraindications).
- Can be observed delayed healing of sluggish wounds, pressure ulcers, leg ulcers (see contraindications).
- Possibility of systemic effects (see warnings: cushingoid syndrome, slowing of growth, acute adrenal insufficiency).
- have been reported: acneiform or pustular eruptions, hypertrichosis, depigmentation.